Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Baker

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Biochemistry|October 19, 2020
An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding ModesNishant K Singh, Jesus A Alonso, Daniel T Harris, et al.
The Journal of Experimental Medicine|September 24, 2014
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicityFei Duan, Jorge Duitama, Sahar Al Seesi, et al.
Nature Communications|January 20, 2025
Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivityJiaqi Ma, Cory M Ayres, Chad A Brambley, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2019
Improving T Cell Receptor On-Target Specificity via Structure-Guided DesignLance M Hellman, Kendra C Foley, Nishant K Singh, et al.
Frontiers in Immunology|December 25, 2023
Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allograftsM Eyad Khorki, Tiffany Shi, Eileen E Cianciolo, et al.
The Journal of Clinical Investigation|December 15, 2020
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejectionCory A Brennick, Mariam M George, Marmar M Moussa, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Distinct sets of molecular characteristics define tumor-rejecting neoantigensAnngela C Adams, Anne M Macy, Elizabeth S Borden, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
Nature Communications|November 6, 2021
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitopeHakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P Englander, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Biochemistry|October 19, 2020
An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding ModesNishant K Singh, Jesus A Alonso, Daniel T Harris, et al.
The Journal of Experimental Medicine|September 24, 2014
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicityFei Duan, Jorge Duitama, Sahar Al Seesi, et al.
Nature Communications|January 20, 2025
Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivityJiaqi Ma, Cory M Ayres, Chad A Brambley, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2019
Improving T Cell Receptor On-Target Specificity via Structure-Guided DesignLance M Hellman, Kendra C Foley, Nishant K Singh, et al.
Frontiers in Immunology|December 25, 2023
Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allograftsM Eyad Khorki, Tiffany Shi, Eileen E Cianciolo, et al.
The Journal of Clinical Investigation|December 15, 2020
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejectionCory A Brennick, Mariam M George, Marmar M Moussa, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Distinct sets of molecular characteristics define tumor-rejecting neoantigensAnngela C Adams, Anne M Macy, Elizabeth S Borden, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
Nature Communications|November 6, 2021
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitopeHakimeh Ebrahimi-Nik, Marmar Moussa, Ryan P Englander, et al.
Pageof 13